Celiac
Disease Study by Alba Therapeutics:
A Two-Part Study, Randomized, Double-Blind, Placebo Controlled Study to a)
Validate a Patient Reported Outcome for Active Celiac Disease and b) to
Evaluate the Efficacy and Safety of investigational product (IP) for the
Treatment of Celiac Disease.